Hank T, Klaiber U, Sahora K, Schindl M, Strobel O. [Surgery for periampullary pancreatic cancer]. Chirurg. 2021;92(9):776–87. https://doi.org/10.1007/s00104-021-01462-1.

Article  PubMed  PubMed Central  Google Scholar 

Ferchichi M, Jouini R, Koubaa W, Khanchel F, Helal I, Hadad D, Bibani N, Chadli-Debbiche A, BenBrahim E. Ampullary and Pancreatic Adenocarcinoma—a Comparative Study. J. Gastrointest. Oncol. Vol 10, No 2 (April 2019) J. Gastrointest. Oncol, 2018.

Yeo C. Shackelford’s surgery of the alimentary tract. 7th Ed. 7th ed. Philadelphia PA: Elsevier/Saunders; 2013.

Google Scholar 

O′Kane GM, Knox JJ. Locally Advanced Pancreatic Cancer: an emerging entity. Curr Probl Cancer. 2018;42(1):12–25. https://doi.org/10.1016/j.currproblcancer.2017.10.006.

Article  PubMed  Google Scholar 

Malayeri R, Ghassemboland M, Ranjpoor F, Maadi A. Gemcitabine/5-Flourouracil/Leucovorin for the treatment of Advanced Pancreatic Carcinoma. Hematol Oncol Stem Cell Ther. 2008;1(4):221–4. https://doi.org/10.1016/s1658-3876(08)50008-2.

Article  CAS  PubMed  Google Scholar 

Melisi D, Budillon A. Pancreatic Cancer: between Bench and Bedside. Current drug targets. United Arab Emirates June. 2012;729–30. https://doi.org/10.2174/138945012800564130.

Zeng S, Pöttler M, Lan B, Grützmann R, Pilarsky C, Yang H. Chemoresistance in Pancreatic Cancer. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20184504.

Article  PubMed  PubMed Central  Google Scholar 

Samm N, Werner K, Rückert F, Saeger HD, Grützmann R, Pilarsky C. The role of apoptosis in the Pathology of Pancreatic Cancer. Cancers (Basel). 2010;3(1):1–16. https://doi.org/10.3390/cancers3010001.

Article  CAS  PubMed  Google Scholar 

Bassett JJ, Robitaille M, Peters AA, Bong AHL, Taing M-W, Wood IA, Sadras F, Roberts-Thomson SJ, Monteith GR. ORAI1 regulates sustained cytosolic free calcium fluctuations during breast Cancer cell apoptosis and apoptotic resistance via a STIM1 independent pathway. FASEB J off Publ Fed Am Soc Exp Biol. 2022;36(1):e22108. https://doi.org/10.1096/fj.202002031RR.

Article  CAS  Google Scholar 

Wang J, Shen J, Zhao K, Hu J, Dong J, Sun J. STIM1 overexpression in Hypoxia Microenvironment contributes to pancreatic carcinoma progression. Cancer Biol Med. 2019;16(1):100–8. https://doi.org/10.20892/j.issn.2095-3941.2018.0304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zoa A, Yang Y, Huang W, Yang J, Wang J, Wang H, Dong M, Tian Y. High expression of Hypoxia-Inducible factor 1-Alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a Meta-analysis and database validation protocol. Transl Cancer Res. 2022;11(9):3080–91. https://doi.org/10.21037/tcr-22-787.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, et al. STIM1, an essential and conserved component of Store-operated Ca2 + Channel function. J Cell Biol. 2005;169(3):435–45. https://doi.org/10.1083/jcb.200502019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren R, Li Y. STIM1 in Tumor Cell Death: Angel or Devil? Cell Death Discov. 2023;9(1):408. https://doi.org/10.1038/s41420-023-01703-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kar S, Niharika; Roy A, Patra SK. Overexpression of SOX2 gene by histone modifications: SOX2 enhances human prostate and breast Cancer progression by Prevention of apoptosis and enhancing cell proliferation. Oncology. 2023;101(9):591–608. https://doi.org/10.1159/000531195.

Article  CAS  PubMed  Google Scholar 

Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y. Histopathologic Evaluation of Stepwise Progression of Pancreatic Carcinoma with Immunohistochemical Analysis of Gastric Epithelial Transcription Factor SOX2: comparison of expression patterns between Invasive Components and cancerous or nonneoplastic int. Pancreas. 2006;32(2):164–70. https://doi.org/10.1097/01.mpa.0000202947.80117.a0.

Article  CAS  PubMed  Google Scholar 

Herreros-Villanueva M, Zhang J-S, Koenig A, Abel EV, Smyrk TC, Bamlet WR, de Narvajas AA-M, Gomez TS, Simeone DM, Bujanda L, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic Cancer cells. Oncogenesis. 2013;2(8):e61–61. https://doi.org/10.1038/oncsis.2013.23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M, Tsutani Y. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in Ampulla of Vater Adenocarcinoma: comparison between expression patterns and histologic subtypes. Oncol Rep. 2006;15(5):1157–61.

CAS  PubMed  Google Scholar 

Wuebben EL, Wilder PJ, Cox JL, Grunkemeyer JA, Caffrey T, Hollingsworth MA, Rizzino A. SOX2 functions as a Molecular Rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget. 2016;7(23):34890–906. https://doi.org/10.18632/oncotarget.8994.

Article  PubMed  PubMed Central  Google Scholar 

Zhao H, Yan G, Zheng L, Zhou Y, Sheng H, Wu L, Zhang Q, Lei J, Zhang J, Xin R, et al. STIM1 is a metabolic checkpoint regulating the Invasion and Metastasis of Hepatocellular Carcinoma. Theranostics. 2020;10(14):6483–99. https://doi.org/10.7150/thno.44025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu B, Yu H-H, Ye H-L, Luo Z-Y, Xiao F. Effects of Stromal Interacting Molecule 1 gene silencing by short hairpin RNA on the Biological Behavior of Human gastric Cancer cells. Mol Med Rep. 2015;12(2):3047–54. https://doi.org/10.3892/mmr.2015.3778.

Article  CAS  PubMed  Google Scholar 

Wang J-Y, Sun J, Huang M-Y, Wang Y-S, Hou M-F, Sun Y, He H, Krishna N, Chiu S-J, Lin S, et al. STIM1 overexpression promotes colorectal Cancer progression, cell motility and COX-2 expression. Oncogene. 2015;34(33):4358–67. https://doi.org/10.1038/onc.2014.366.

Article  CAS  PubMed  Google Scholar 

Huang H-K, Lin Y-H, Chang H-A, Lai Y-S, Chen Y-C, Huang S-C, Chou C-Y, Chiu W-T. Chemoresistant Ovarian Cancer enhances its Migration abilities by increasing Store-operated ca(2+) entry-mediated turnover of focal adhesions. J Biomed Sci. 2020;27(1):36. https://doi.org/10.1186/s12929-020-00630-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang X, Zhang N, Pan H, Xie J, Han W. Development of store-operated calcium entry-targeted compounds in Cancer. Front Pharmacol. 2021;12:688244. https://doi.org/10.3389/fphar.2021.688244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhamed AS, Alqinyah M, Alsufayan MA, Alhaydan IA, Alassmrry YA, Alnefaie HO, Algahtani MM, Alghaith AF, Alhamami HN, Albogami AM, et al. Blockade of store-operated calcium entry sensitizes breast Cancer cells to Cisplatin Therapy via modulating inflammatory response. Saudi Pharm J. 2023;31(2):245–54. https://doi.org/10.1016/j.jsps.2022.12.009.

Article  CAS  PubMed  Google Scholar 

Guo L, Mohanty A, Singhal S, Srivastava S, Nam A, Warden C, Ramisetty S, Yuan Y-C, Cho H, Wu X, et al. Targeting ITGB4/SOX2-Driven Lung Cancer Stem cells using proteasome inhibitors. iScience. 2023;26(8):107302. https://doi.org/10.1016/j.isci.2023.107302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Sun Y. Targeting Oncogenic SOX2 in Human Cancer cells: therapeutic application. Protein Cell. 2020;11(2):82–4. https://doi.org/10.1007/s13238-019-00673-x.

Article  CAS  PubMed  Google Scholar 

Chun YS, Pawlik TM, Vauthey J-N. 8th Edition of the AJCC Cancer staging Manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845–7. https://doi.org/10.1245/s10434-017-6025-x.

Article  PubMed  Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA. The 2019 WHO classification of Tumours of the Digestive System. Histopathology. 2020;76(2):182–8. https://doi.org/10.1111/his.13975.

Article  PubMed  Google Scholar 

Hwang HK, Kim H-I, Kim SH, Choi J, Kang CM, Kim KS, Lee WJ. Prognostic impact of the Tumor-Infiltrating Regulatory T-Cell (Foxp3(+))/Activated cytotoxic T lymphocyte (Granzyme B(+)) ratio on Resected Left-Sided Pancreatic Cancer. Oncol Lett. 2016;12(6):4477–84. https://doi.org/10.3892/ol.2016.5252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chrysovergis A, Papanikolaou VS, Tsiambas E, Ragos V, Peschos D, Kyrodimos E. Digital Analysis of BCL2 expression in laryngeal squamous cell carcinoma. Anticancer Res. 2019;39(3):1253–7. https://doi.org/10.21873/anticanres.13235.

Article  CAS  PubMed  Google Scholar 

Song S, Wang B, Gu S, Li X, Sun S. Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. Oncol Lett. 2017;14(6):7849–61. https://doi.org/10.3892/ol.2017.7218.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zarella MD, Heintzelman RC, Popnikolov NK, Garcia FU. BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast Cancer recurrence score. BMC Clin Pathol. 2018;18:14. https://doi.org/10.1186/s12907-018-0082-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kondratska K, Kondratskyi A, Yassine M, Lemonnier L, Lepage G, Morabito A, Skryma R, Prevarskaya N. Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Biochim Biophys Acta. 2014;1843(10):2263–9. https://doi.org/10.1016/j.bbamcr.2014.02.012.

Article  CA